首页> 外文OA文献 >Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial

【2h】

Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial

机译：免疫调节剂MGN1703（Toll样受体9（TLR9）激动剂）在转移性结直肠癌和化疗后疾病控制的患者中的维持治疗：一项随机，双盲，安慰剂对照试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hans-Joachim Schmoll; Burghardt Wittig; Dirk Arnold; Jorge Riera-Knorrenschild; Dieter Nitsche; Hendrik Kroening; Frank Mayer; Johannes Andel; Reinhard Ziebermayr; Werner Scheithauer;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: A randomised, double-blind, placebo-controlled trial [J] . SchmollH.-J., WittigB., ArnoldD., Journal of Cancer Research and Clinical Oncology . 2014,第9期

机译：免疫调节剂MGN1703（Toll样受体9（TLR9）激动剂）在转移性结直肠癌和化疗后疾病控制的患者中的维持治疗：一项随机，双盲，安慰剂对照试验
2. S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial [J] . H Schmoll, BW Wittig, DA Arnold, Journal for ImmunoTherapy of Cancer . 2014,第S2期

机译：S5。论文：TLR-9激动剂MGN1703维持转移性结直肠癌的治疗：IMPACT试验中活性的临床和免疫学预测性预处理因素
3. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): A randomised, double-blind, placebo-controlled trial [J] . UzunS., DjaminR.S., KluytmansJ.A.J.W., The lancet. Respiratory medicine. . 2014,第5期

机译：阿奇霉素维持治疗对慢性阻塞性肺疾病频繁加重的患者（COLUMBUS）：一项随机，双盲，安慰剂对照试验
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Maintenance treatment with the immunomodulator MGN1703 a Toll-like receptor 9 (TLR9) agonist in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised double-blind placebo-controlled trial [O] . Hans-Joachim Schmoll, Burghardt Wittig, Dirk Arnold, -1

机译：免疫调节剂MGN1703（Toll样受体9（TLR9）激动剂）在转移性结直肠癌和化疗后疾病控制的患者中的维持治疗：一项随机双盲安慰剂对照试验
7. Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial [O] . Mayer, Frank 2014

机译：免疫调节剂MGN1703（Toll样受体9（TLR9）激动剂）在转移性结直肠癌和化疗后疾病控制的患者中的维持治疗：一项随机，双盲，安慰剂对照试验

Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial

著录项

引文网络

相似文献

相关主题

期刊订阅